President Biden and Sen. Bernie Sanders (I-Vt.) continued their calls for lowered drug pricing in an op-ed published Tuesday, citing the high cost of the weight loss products manufactured by Novo Nordisk and Eli Lilly. Biden and Sanders echoed the common criticism of drug companies charging the U.S. significantly more for prescription drugs when compared to peer nations, in the op-ed published in USA Today. They pointed to Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro, which the U.S. pays up to six times the price for, compared to what countries like Canada and Germany pay. "It is most certainly not Americans’ patriotic duty to pay high drug prices at home so others
Hence then, the article about biden sanders call out novo nordisk eli lilly for high drug costs in op ed was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Biden, Sanders call out Novo Nordisk, Eli Lilly for high drug costs in op-ed )